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410a Tuesday, February 28, 2012more rigorous physical model combined with effective sampling of molecular
configurations is critical for binding affinity prediction to chemical accuracy,
which is defined as within one order of magnitude of the true equilibrium dis-
sociation constant. We have demonstrated that electrostatic interactions, espe-
cially electronic polarization, are critical for protein-ligand recognition due to
the significant change in electrostatic environments between bulk water and
protein pockets and have achieved encouraging success in treating charged spe-
cies using the polarizable Atomic Multipole Optimized Energetics for Biomo-
lecular Applications (AMOEBA) force field. To maintain accuracy while also
achieving efficiency, AMOEBA has been combined with the Orthogonal Space
Random Walk en-
hanced alchemical
free energy algo-
rithm. Here we pres-
ent applications of
this strategy for the
computation of pro-
tein-ligand binding
affinities and, for the
first time, drug solu-
bility from alchemi-
cal simulations using
the Force Field X
software.2083-Plat
MloK1 Ligand Binding Simulations Indicate an Induced-Fit Mechanism
Be´la Voß1, Sebastian Peuker2, U. Benjamin Kaupp2, Helmut Grubmu¨ller1.
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Many ion channels such as the MloK1 channel are steered by ligand binding via
conformational changes. Mainly two binding mechanisms have been proposed,
induced fit and conformational selection. Using molecular dynamics simula-
tions, we studied ligand binding of cyclic adeonise monophosphate at the cyclic
nucleotide binding domain of the MloK1 ion channel of Mesorizobium loti. For
this binding domain, both crystal and NMR structures have been determined for
both the ligand free as well as for the ligand bound conformation.
In the simulations, spontaneous binding was observed, which enabled us to de-
termine reaction coordinates for the ligand binding as well as for the associated
conformational change of the protein. We used a combination of force probe
simulations, umbrella sampling, and unbiased simulations to determine poten-
tials of mean force along these reaction coordinates, transition rates, as well as
free energy differences and barriers between the most relevant substates.
Our results are compared with measured affinities and kinetics, and suggest an
induced fit-mechanism.
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How drugs bind to their receptors—from initial association, through entry into
the binding pocket, to adoption of the final bound pose—has remained un-
known, even for G-protein-coupled receptor modulators, which constitute
one-third of all drugs. We captured this pharmaceutically critical process in
atomic detail using the first unbiased molecular dynamics simulations in which
drug molecules spontaneously associate with G-protein-coupled receptors to
achieve final poses matching those determined crystallographically (PNAS
108:13118 (2011)). We found that several beta blockers and a beta agonist
all traverse the same dominant pathway as they bind to the b1- and b2-adrener-
gic receptors, initially associating with a vestibule on
each receptor’s extracellular surface. Surprisingly, this
association, at a distance of 15 A˚ from the binding
pocket, often presents the largest energetic barrier to
binding, despite the fact that subsequent entry into the
pocket requires the receptor to deform and the drug to
squeeze through a narrow passage. The early barrier
may reflect the substantial dehydration that occurs as
the drug associates with the vestibule. Our atomic-level
description of the binding process suggests opportunities
for allosteric modulation and provides a structural foun-
dation for future optimization of binding and unbinding
rates.2085-Plat
A General Prediction Method of Scorpion Toxins’ Kv-Channel Selectivity
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Po-chia Chen, Serdar Kuyucak.
School of Physics, University of Sydney, Australia.
The active components of animal venoms are potentially useful in many elec-
trophysiological and pharmacological applications due to their highly selective
nature. Of this rich concoction, the binding mechanisms of many toxin types
remain to be elucidated. We therefore present a preliminary method to deduce
the selectivity profile of a peptide toxin against related channels by means of
docking simulations. This is tested on the family of a-KTx scorpion toxins,
for which structural and limited affinity data are available for over 20 toxins
across seven sub-families. Docking simulations against Kv1.1, Kv1.2 and
Kv1.3 were carried out under both blind-docking trials and common-lysine-
motif trials, using the program HADDOCK.
This study reports on a selection of toxins for which validation can be best pro-
vided, given current limitations of docking accuracy. The general selectivity
profiles of toxin-subfamilies can be deduced via consensus between closely re-
lated toxin-channel pairings. In particular, HADDOCK was able to classify
a-KTX2 toxins as universal binders and a-KTX3 toxins as Kv1.3-selective
binders. An estima-
tion of individual se-
lectivity profiles can
be further deduced by
program performance.
This method is ex-
pected to be useful in
the refinement of
toxins for channel-
subtype targetting.2086-Plat
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Matthew R. Rosenberg, Nicole C. Norris, Llara M. Weaver,
Marco G. Casarotto.
Australian National University, Canberra, Australia.
Virus ion channels are small (3-15 kD) peptides that aggregate to form ion
channels that are important for viral infection1. As viruses continue to pose
a major worldwide health problem, these ion channels represent an exciting
new target for therapeutic intervention. Viral ion channels that have been pre-
viously identified include Vpu of the human immunodeficiency virus (HIV) and
P7 of Hepatitis C however it is the M2 influenza A protein that represents the
best exploited ion channel drug target so far.
The proton-selective M2 ion channel is the target of the adamantane family of
drug inhibitors. Use of the two most common adamantane inhibitors, amanta-
dine and rimantadine have declined steadily over recent years due to the emer-
gence of adamantane-resistant flu strains. We have conducted a series of
surface plasmon resonance experiments designed to measure the affinity be-
tween several ion channel inhibitors and M22. By examining drug binding to
a number of mutant M2 constructs (derived from adamantane-resistant strains),
it was possible to establish the location of the drug binding sites and to ratio-
nalise the effect on drug binding of specific mutant residues. In light of these
results, the prospect for future development of a new generation of M2 inhib-
itors will be discussed. Moreover, we explore the possibility of expanding this
field of research to incorporate ion channel proteins from other viruses.
1. Gonzalez, M and Carrasco, L (2003). FEBS Lett. (2003) 552(1):28-34.
2. Rosenberg, M and Casarotto, M (2010) PNAS 107(31):13866-71.
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Small molecule kinase inhibitors have recently demonstrated dramatic po-
tential for treating cancers caused by dysregulated protein kinases. The ef-
ficacy of these compounds is due to their ability to selectively target
particular protein kinases, and this selectivity is remarkable given the fact
that they bind to the ATP-binding site of the kinase domain, which is highly
conserved in sequence across this large protein family. The origin of this
selectivity is unknown, but must relate to differences in physical properties
of the ATP-binding site among members of this protein family. The goal of
this project is to assess how the evolutionary divergence of sequence and
structure in the human kinome translates into variation in ATP-binding
site electrostatics, and how this variation can be exploited to design highly
selective inhibitors. I am using a clinically important class of kinase
Tuesday, February 28, 2012 411ainhibitors, the 4-anilinoquinazolines/4-anilinoquinolines, to introduce vibra-
tional probes of electric field, which measure electrostatics via the vibra-
tional Stark effect, into the ATP-binding sites of different kinases. The
results yield direct insight into how chemical changes within this inhibitor
class influence the selectivity for particular kinases, potentially yielding
a method for rationally designing selective inhibitors.
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PSD-95/DlgA/ZO-1 (PDZ) domains are among the most abundant protein-
protein interaction domains in the human proteome and typically bind the
4-10 C-terminal residues of its interaction partner with exquisite specificity.
We used two homologous PDZ domains from the Tiam-family of guanine nu-
cleotide exchange factors to investigate PDZ specificity. The Tiam1 and Tiam2
PDZ domains have overlapping but distinct ligand binding specificity, and this
is exemplified by their unique preferences for C-terminal peptides derived from
the syndecan1, Caspr4 and neurexin1 adhesion proteins. The Tiam1 PDZ do-
main binds syndecan1 and Caspr4 but not neurexin1, while the Tiam2 PDZ do-
main binds Caspr4 and neurexin1 but not syndecan1. Amino acid sequence
comparison of Tiam-family PDZ domains revealed that four residues critical
for ligand specificity are not conserved. Remarkably, substitution of these
four residues in the Tiam1 PDZ for those found in the Tiam2 PDZ domain
switched ligand specificity. To understand the structural and dynamic basis
for this change in specificity we used X-ray crystallography and solution
NMR methods, respectively. We determined the crystal structures of wild
type Tiam1 PDZ domain bound to syndecan1 and phosphorylated syndecan1
peptides and the Tiam1 PDZ quadruple mutant (QM) bound to Caspr4 and neu-
rexin1 peptides. Comparison of the crystal structures of the Tiam1 PDZ-
syndecan1 and PDZ-phosphorylated syndecan1 showed that a distinct specific-
ity pocket is used to accommodate the phosphoryl group. The crystal structure
of the Tiam1 QM PDZ domain showed a unique side chain stacking interaction
between aromatic residues in the PDZ domain and the Caspr4 ligand. Side
chain methyl relaxation experiments revealed distinct patterns of dynamics
in the Tiam1 PDZ-syndecan1 and PDZ-Caspr4 complexes. Collectively, the
structures and dynamics of physiologically-based PDZ domain complexes
are contributing to understanding the origin of PDZ specificity and function
of Tiam-family PDZ domains.
Platform: Channel Regulation & Modulation
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Despite its long history of use and abuse in human culture, the molecular basis
for alcohol action in the brain is poorly understood. The recent determination of
the atomic-scale structure of GLIC, a prokaryotic member of the pentameric
ligand-gated ion channel (pLGIC) family, provides a unique opportunity to
characterize the structural basis for modulation of these channels, many of
which are alcohol targets in brain. We observed bimodal modulation of
GLIC by n-alcohols, similar to some eukaryotic pLGICs: methanol and ethanol
weakly potentiated proton-activated currents in GLIC, whereas n-alcohols
larger than ethanol inhibited them. Mapping of residues important to alcohol
modulation of ionotropic receptors for glycine, GABA, and acetylcholine
onto GLIC revealed their proximity to transmembrane cavities that may accom-
modate one or more alcohol molecules. Site-directed mutations in the pore-
liningM2 helix allowed the identification of four residues that influence alcohol
potentiation, with the direction of their effects reflecting helical structure. At
one of the potentiation-enhancing residues, decreased side chain volume con-
verted GLIC into a highly ethanol-sensitive channel, comparable to its eukary-
otic relatives. Covalent labeling of M2 positions with a methanethiosulfonate
reagent further implicated residues at the extracellular end of the helix in alco-
hol binding. Molecular dynamics simulations elucidated the structural conse-
quences of a potentiation-enhancing mutation and suggested a structural
mechanism for alcohol potentiation via interaction with a transmembrane cav-
ity previously termed the ‘‘linking tunnel.’’ These results provide a uniquestructural model for independent potentiating and inhibitory interactions of
n-alcohols with a pLGIC family member.
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Ceramide Channel Regulation by Bcl-2 Family Proteins: Molecular
Insights
Meenu N. Perera, Shang-Hsuan Lin, Kaiti Chang, Marco Colombini.
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The sphingolipid, ceramide can self-assemble in phospholipid membranes to
form large channels capable of translocating proteins through membranes.
Electronmicroscopic visualization and electrophysiological measurements re-
veal a range of pore sizes with the most frequent being 10 nm in diameter.
The channel size and the propensity to form channels are controlled by the
apoptosis-related Bcl-2 family proteins. Bcl-xL favors channel disassembly
whereas Bax favors channel growth. By using ceramide analogs we have iden-
tified regions of the ceramide molecule that are recognized by these proteins
and through which the proteins exert their influence. The ability of Bax to en-
hance ceramide channel formation was sensitive to the stereochemistry of the
ceramide head group and the hydrogen bonding ability of the amide nitrogen
whereas the ability of Bcl-xL to favor channel disassembly was highly sensitive
to the length of the fatty acyl chain length of ceramide. It is likely that the N-
acyl chain is binding to the hydrophobic pocket on Bcl-xL because the action of
Bcl-xL is blocked by 2-methoxyantimycin A3, ABT-737 and ABT-263, inhib-
itors that specifically bind at this site. The results are consistent with the con-
clusion that the highly specific binding of these proteins to the ceramide
channel results in structural changes that propagate throughout the channel in
an allosteric manner resulting in a disturbance of the dynamic equilibrium be-
tween ceramides in the channel and ceramides in other forms in the membrane.
Depending on the influence on the dynamic equilibrium channel growth or dis-
assembly may be favored. (Supported by NSF grant: MCB-1023008)
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M-type (Kv7.2/7.3) channels are activated by the membrane phospholipid
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) [Li et al., 2005: J.Neurosci.,
25,9825], through interaction with a cluster of basic residues in the C-terminus
[Hernandez et al, 2008: J.Gen.Physiol., 132,361]. However, little is known of
the phospholipid specificity and requirements for this activation. We have ex-
plored this using inside-out membrane patches from CHO cells stably-
expressing Kv7.2 and Kv7.3 subunits and held at a constant voltage ca. 20
mV. The dioctanoyl mono-, di- and tri-phosphatidylinositides DiC8-PI(4)P,
DiC8-PI(4,5)P2 and DiC8-PI(3,4,5)P3 all produced biphasic Popen-concentra-
tion curves, maximizing at Popen ~0.8. EC50s for the ‘high-affinity’ component
1 (maximum Popen ~0.2) were similar at ~1 mM; ‘low-affinity’ EC50s were in-
versely proportional to the number of phosphates (DiC8-PI(4)P ~100 mM,
DiC8-PI(4,5)P2 ~50 mM, DiC8-PI(3,4,5)P3 ~35 mM). In contrast, the inositol
phosphates I(1,4,5)P3 and I(4,5)P2 neither activated nor inhibited the channels
up to 300 mM, suggesting a crucial role for the lipophilic moiety. This was
tested further using sphingosine-1-phosphate (S-1-P), fingolimod phosphate
(FTY720-P) and 1-oleoyl lysophosphatidic acid (LPA). All three activated
the Kv7.2/7.3 channels, to Popen values at 100 mM of ~0.8 (LPA), 0.15 (S-1-
P) and 0.022 (FTY720-P). In each case ‘high’ and ‘low’ affinity components
to the activation curves could be discerned, with EC50s of 1.5 and 40 mM
(LPA), 3 and 160 mM (S-1-P) and 0.5 and 61 mM (FTY720-P). No channel ac-
tivation was observed using membrane lipids devoid of phosphate groups
(D-erythrosphingosine, fingolimod, phosphatidylglycerol and phosphatidyl-
choline, all at 100 mM). Thus, M-channels can be activated in a rather similar
manner by a range of membrane lipids, the minimal requirements at concentra-
tions tested being one or more terminal phosphates and a lipophilic domain.
Supported by Wellcome Trust grant 085419.
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Molecular diversity of ion channel structure and function underlies variability
in electrical signaling in nerve, muscle, and non-excitable cells. Regulation by
variable auxiliary subunits is a major mechanism to generate tissue- or cell-
specific diversity of ion channel function.Mammalian large-conductance, volt-
age and calcium-activated potassium (BK, KCa1.1) channels are ubiquitously
expressed with diverse functions in different tissues or cell types, consisting
of the pore-forming, voltage- and Ca2þ-sensing a-subunits (BKa), or together
